Business Description
Hubei Goto Biopharm Co Ltd
ISIN : CNE100004K94
Share Class Description:
SZSE:300966: Class ACompare
Compare
Traded in other countries / regions
300966.China IPO Date
2021-04-09Description
Hubei Goto Biopharm Co Ltd is engaged in the research and development, production, and sales of steroidal hormone drug raw materials.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.13 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.08 | |||||
| Debt-to-EBITDA | -116.26 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.1 | |||||
| Beneish M-Score | -2.9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -3.3 | |||||
| 3-Year EBITDA Growth Rate | -20 | |||||
| 3-Year EPS without NRI Growth Rate | -30 | |||||
| 3-Year FCF Growth Rate | -269.1 | |||||
| 3-Year Book Growth Rate | 10.1 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.39 | |||||
| 9-Day RSI | 51.51 | |||||
| 14-Day RSI | 51.65 | |||||
| 6-1 Month Momentum % | 9.86 | |||||
| 12-1 Month Momentum % | -16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.48 | |||||
| Cash Ratio | 0.17 | |||||
| Days Inventory | 315.74 | |||||
| Days Sales Outstanding | 130.35 | |||||
| Days Payable | 379.38 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.09 | |||||
| Forward Dividend Yield % | 0.09 | |||||
| 5-Year Yield-on-Cost % | 0.09 | |||||
| 3-Year Average Share Buyback Ratio | -10.1 | |||||
| Shareholder Yield % | -7.72 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.17 | |||||
| Operating Margin % | -0.66 | |||||
| Net Margin % | -2.55 | |||||
| FCF Margin % | -47.69 | |||||
| ROE % | -1.47 | |||||
| ROA % | -0.55 | |||||
| ROIC % | -0.12 | |||||
| ROC (Joel Greenblatt) % | -0.55 | |||||
| ROCE % | -0.48 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 3.92 | |||||
| PB Ratio | 2.29 | |||||
| Price-to-Tangible-Book | 2.42 | |||||
| Price-to-Operating-Cash-Flow | 14.22 | |||||
| EV-to-EBIT | -346.66 | |||||
| EV-to-EBITDA | -346.66 | |||||
| EV-to-Revenue | 5.54 | |||||
| EV-to-FCF | -11.5 | |||||
| Earnings Yield (Greenblatt) % | -0.29 | |||||
| FCF Yield % | -12.13 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hubei Goto Biopharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 546.751 | ||
| EPS (TTM) (Â¥) | -0.12 | ||
| Beta | 1.23 | ||
| Volatility % | 40.58 | ||
| 14-Day RSI | 51.65 | ||
| 14-Day ATR (Â¥) | 0.920424 | ||
| 20-Day SMA (Â¥) | 18.776 | ||
| 12-1 Month Momentum % | -16 | ||
| 52-Week Range (Â¥) | 12.03 - 25.7 | ||
| Shares Outstanding (Mil) | 115.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hubei Goto Biopharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hubei Goto Biopharm Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Hubei Goto Biopharm Co Ltd Frequently Asked Questions
What is Hubei Goto Biopharm Co Ltd(SZSE:300966)'s stock price today?
The current price of SZSE:300966 is ¥18.65. The 52 week high of SZSE:300966 is ¥25.70 and 52 week low is ¥12.03.
When is next earnings date of Hubei Goto Biopharm Co Ltd(SZSE:300966)?
The next earnings date of Hubei Goto Biopharm Co Ltd(SZSE:300966) is .
Does Hubei Goto Biopharm Co Ltd(SZSE:300966) pay dividends? If so, how much?
The Dividend Yield %  of Hubei Goto Biopharm Co Ltd(SZSE:300966) is 0.09% (As of Today), Highest Dividend Payout Ratio of Hubei Goto Biopharm Co Ltd(SZSE:300966) was 0.43. The lowest was 0.43. And the median was 0.43. The  Forward Dividend Yield % of Hubei Goto Biopharm Co Ltd(SZSE:300966) is 0.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers